“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review” (2025) The Review of Diabetic Studies, pp. 1039–1048. doi:10.70082/x94dvz94.